Growth failure, tardive dyskinesia, megacolon development, and hepatic damage in neonatal rats following exposure to trimethobenzamide in utero
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.24, ss.1176-1180, 2011 (SCI İndekslerine Giren Dergi)
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Objective. Trimethobenzamide (TMB) has a pregnancy category C labeling. Tardive dyskinesia and gastrointestinal involvement in neonates were not described earlier. We aimed to investigate neurological, developmental, and hepatic effects of TMB.